| 1 |
30418193 | Hydroxychavicol sensitizes imatinib-resistant chronic myelogenous leukemia cells to TRAIL-induced apoptosis by ROS-mediated IAP downregulation. | 2019 Feb |
3 |
| 2 |
31263034 | Editor's Note: Cotreatment with STI-571 Enhances Tumor Necrosis Factor α-related Apoptosis-inducing Ligand (TRAIL or Apo-2L)-induced Apoptosis of Bcr-Abl-positive Human Acute Leukemia Cells. | 2019 Jul 1 |
2 |
| 3 |
22665066 | BCR-ABL regulates death receptor expression for TNF-related apoptosis-inducing ligand (TRAIL) in Philadelphia chromosome-positive leukemia. | 2013 Mar 28 |
1 |
| 4 |
24147007 | Persistent inhibition of ABL tyrosine kinase causes enhanced apoptotic response to TRAIL and disrupts the pro-apoptotic effect of chloroquine. | 2013 |
1 |
| 5 |
22133064 | Targeting PDGFR-β in Cholangiocarcinoma. | 2012 Mar |
1 |
| 6 |
22462553 | STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death. | 2012 Mar 30 |
5 |
| 7 |
20838376 | BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients. | 2011 Jan 13 |
1 |
| 8 |
20564078 | Platelet-derived growth factor receptor beta inhibition increases tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity: imatinib and TRAIL dual therapy. | 2010 Aug 15 |
3 |
| 9 |
19203346 | Sensitization of imatinib-resistant CML cells to TRAIL-induced apoptosis is mediated through down-regulation of Bcr-Abl as well as c-FLIP. | 2009 Apr 28 |
4 |
| 10 |
17432976 | Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients. | 2007 May |
2 |
| 11 |
17504122 | The kinase inhibitor imatinib--an immunosuppressive drug? | 2007 May |
1 |
| 12 |
17900262 | Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand. | 2007 Dec |
3 |
| 13 |
16983347 | Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation. | 2006 Dec 7 |
4 |
| 14 |
11234890 | Cotreatment with STI-571 enhances tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL or apo-2L)-induced apoptosis of Bcr-Abl-positive human acute leukemia cells. | 2001 Feb |
6 |